| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |